Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Gilead Sciences
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Immunocore Ltd
National Cancer Institute (NCI)
Hoffmann-La Roche
Daiichi Sankyo
Janssen Research & Development, LLC
Syndax Pharmaceuticals
AstraZeneca
AstraZeneca
Pfizer
Tesaro, Inc.
Merck Sharp & Dohme LLC
Novartis
Hoffmann-La Roche
BeOne Medicines
Ipsen
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
AstraZeneca
Pfizer
AstraZeneca
AstraZeneca
Gamida Cell ltd
Janssen Research & Development, LLC
Seagen Inc.
Eisai Inc.
Merck Sharp & Dohme LLC
Novartis
BeOne Medicines
AstraZeneca
Bristol-Myers Squibb